Log in

Liver fibrosis assessment using 99mTc-GSA SPECT/CT fusion imaging

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Purpose

To determine the utility of mean standardized uptake value (SUVmean) of whole liver measured by 99mTc-GSA SPECT/CT fusion imaging, for evaluation of liver fibrosis.

Materials and methods

Eighty-six patients who underwent hepatectomy were enrolled, and were classified into the non-fibrosis or fibrosis group based on the pathological findings in the resected liver specimen. Univariate and multivariate analyses were performed between the two groups on four blood biochemical indices (albumin, total bilirubin, platelet count, and prothrombin time activity) and two 99mTc-GSA scintigraphy-derived liver function indices (LHL15 and SUVmean) to evaluate the independent predictive value for severe fibrosis. The diagnostic value of the index for severe fibrosis was assessed by calculating the area under the receiver operating characteristic curve.

Results

Multivariate analysis showed that prothrombin time activity [odds ratio (OR) 0.519], LHL15 (OR 0.513), and SUVmean (OR 0.168) significantly correlated with liver fibrosis. SUVmean showed the largest area under the curve, with value of 0.804, 0.730 for platelet count, 0.717 for LHL15, and 0.668 for prothrombin time activity. The optimal cut-off value for SUVmean was 6.7, which yielded 62.9% sensitivity and 96.9% specificity.

Conclusions

SUVmean measured by 99mTc-GSA SPECT/CT fusion imaging enables highly accurate prediction of severe liver fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg. 1999;229:210–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364–72.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Zarzavadjian A, Bian L, Costi R, Sbai-Idrissi MS, Smadja C. Liver resection and metabolic disorders: an undescribed mechanism leading to postoperative mortality. World J Gastroenterol. 2014;20:55–62.

    Google Scholar 

  4. Wang Q, Fiel M, Blank S, Luan W, Kadri H, Kim KW, et al. Impact of liver fibrosis on prognosis following liver resection for hepatitis B-associated hepatocellular carcinoma. Br J Cancer. 2013;109:573–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Sumiyoshi T, Shima Y, Okabayashi T, Noda Y, Hata Y, Murata Y, et al. Functional discrepancy between two liver lobes after hemilobe biliary drainage in patients with jaundice and bile duct cancer: an appraisal using 99mTc-GSA SPECT/CT fusion. Radiology. 2014;273:444–51.

    Article  PubMed  Google Scholar 

  6. Sobue G, Kosaka A. Asialoglycoproteinemia in a case of primary hepatic cancer. Hepatogastroenterology. 1980;27:200–3.

    CAS  PubMed  Google Scholar 

  7. Marshall JS, Green AM, Pensky J, Williams S, Zinn A, Carlson DM. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage. J Clin Investig. 1974;54:555–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Okabayashi T, Shima Y, Morita S, Shimada Y, Sumiyoshi T, Sui K, et al. Liver function assessment using technetium 99m-Galactosyl single-photon emission computed tomography/CT fusion imaging: a prospective trial. J Am Coll Surg. 2017;225:789–97.

    Article  PubMed  Google Scholar 

  9. Okabe H, Beppu T, Hayashi H, Mima K, Nakagawa S, Kuroki H, et al. Rank classification based on the combination of indocyanine green retention rate at 15 min and (99m) Tc-DTPA-galactosyl human serum albumin scintigraphy predicts the safety of hepatic resection. Nucl Med Commun. 2014;35:478–83.

    Article  CAS  PubMed  Google Scholar 

  10. Hasegawa D, Onishi H. Evaluation of accuracy for quantitative predictor of hepatic functional reserve using planar and SPECT images in the 99mTc-GSA scintigraphy. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73:1055–60.

    Article  PubMed  Google Scholar 

  11. Suh MS, Lee WW, Kim YK, Yun PY, Kim SE. Maximum standardized uptake value of 99mTc hydroxymethylene diphosphonate SPECT/CT for the evaluation of temporomandibular joint disorder. Radiology. 2016;280:890–6.

    Article  PubMed  Google Scholar 

  12. Kinahan PE, Fletcher JW. Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy. Semin Ultrasound CT MR. 2010;31:496–505.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kokudo N, Vera DR, Makuuchi M. Clinical application of TcGSA. Nucl Med Biol. 2003;30:845–9.

    Article  CAS  PubMed  Google Scholar 

  14. Kwon AH, Ha-Kawa SK, Uetsuji S, Kamiyama Y, Tanaka Y. Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection. Surgery. 1995;117:429–34.

    Article  CAS  PubMed  Google Scholar 

  15. Oshiro Y, Ohkohchi N. Three-dimensional liver surgery simulation: computer-assisted surgical planning with three-dimensional simulation software and three-dimensional printing. Tissue Eng Part A. 2017;23:474–80.

    Article  PubMed  Google Scholar 

  16. Ludwig J (1993) The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 105:274–278

  17. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V et al (2007) FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 46:32–36

  18. Jabor A, Kubíček Z, Fraňková S, Šenkeříková R, Franeková J. Enhanced liver fibrosis (ELF) score: Reference ranges, biological variation in healthy subjects, and analytical considerations. Clin Chim Acta. 2018;483:291–5.

    Article  CAS  PubMed  Google Scholar 

  19. Gudowska M, Cylwik B, Chrostek L. The role of serum hyaluronic acid determination in the diagnosis of liver fibrosis. Acta Biochim Pol. 2017;64:451–7.

    Article  CAS  PubMed  Google Scholar 

  20. Khan S, Subedi D, Chowdhury UMM (2006) Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis. Postgrad Med J 82:353–354

  21. Murawaki Y, Ikuta Y, Nishimura Y, Koda M, Kawasaki H. Serum markers for connective tissue turnover in patients with chronic hepatitis B and chronic hepatitis C: a comparative analysis. J Hepatol. 1995;23:145–52.

    Article  CAS  PubMed  Google Scholar 

  22. Bulatova IA, Schekotova AP, KrivtsovAV, Schekotov VV, Pavlov AI (2015) The noninvasive evaluation of degree of expression of fibrosis of liver and significance of polymorphism of gene of hyaluronic acid under chronic hepatitis C. Klin Lab Diagn 60:18–21

Download references

Funding

We received no financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tatsuaki Sumiyoshi.

Ethics declarations

Conflict of interest

We have no conflict of interest to declare.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethics committee of the Kochi Health Sciences Center and with the 1964 Helsinki declaration. The study was approved by the institutional review board of Kochi Health Sciences Center, with a waiver of informed consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tokorodani, R., Sumiyoshi, T., Okabayashi, T. et al. Liver fibrosis assessment using 99mTc-GSA SPECT/CT fusion imaging. Jpn J Radiol 37, 315–320 (2019). https://doi.org/10.1007/s11604-019-00810-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-019-00810-w

Keywords

Navigation